PTG-100, AN ORAL GUT-RESTRICTED PEPTIDE α4β7 ANTAGONIST, INDUCES CLINICAL AND HISTOLOGIC REMISSION IN PATIENTS WITH MODERATE TO SEVERELY ACTIVE ULCERATIVE COLITIS

William Sandborn  1     Brian Bressler  2     Scott D. Lee  3     Raj Bhandari  4     Bittoo Kanwar  5     Lucio Tozzi  6     Richard Shames     Geert R. D'Haens     Jean-Frederic Colombel     Stefan Schreiber     Silvio Danese     Rish K. Pai     Brian G. Feagan    
1 University of California - San Diego,La Jolla, California,United States
2 University of British Columbia,Vancouver,Canada
3 University of Washington Dept. of Gastroenterology,Seattle,United States
4 Delta Research Partners,Monroe,United States
5 Protagonist Therapeutics,Newark,United States
6 Protagonist Therapeutics,Newark,United States;;

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing